| Authors: |
Haidar G; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address: haidarg@upmc.edu., Thomas S; Biometrics, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA; Chiesi USA, Cary, NC, USA., Loubet P; Service des Maladies Infectieuses et Tropicales, CHU Nîmes Carémeau, Université de Montpellier, Nîmes, France., Baker RI; Western Australia Centre for Thrombosis and Haemostasis, Murdoch University, Perth, WA, Australia; Clinical Research Unit, Perth Blood Institute, Perth, WA, Australia; Hollywood Hospital Haemophilia Centre, Haematology Academic Unit, Perth, WA, Australia., Benfield T; Department of Infectious Diseases, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark., Boonyaratanakornkit J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Department of Medicine, University of Washington, Seattle, WA, USA., Kiertiburanakul S; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Kim AHJ; Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Longbrake EE; Department of Neurology, Yale School of Medicine, New Haven, CT, USA., Molina JM; University of Paris Cité, INSERM U944, Hôpital Saint-Louis, Lariboisière Hospitals, Assistance Publique Hopitaux de Paris, Paris, France., Paredes R; Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Department of Infectious Diseases and IrsiCaixa, University Hospital Germans Trias i Pujol, Barcelona, Spain., Tucker D; Haematology Research Department, Haematology Clinic, Royal Cornwall Hospital NHS Trust, Truro, UK., Uriel A; Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital (Manchester University NHS Foundation Trust), Manchester, UK., Weinmann-Menke J; First Department of Medicine and Research Center for Immunotherapy, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Aksyuk AA; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA., Clegg LE; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA., Currie A; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Cambridge, UK., Yang H; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA., Flyrin K; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Mölndal, Sweden., Gibbs M; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Cambridge, UK., Shroff M; Patient Safety, Chief Medical Office, Research & Development, AstraZeneca, Waltham, MA, USA., Perez JL; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA., Chang LJ; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA., Cohen TS; Vaccines & Immune Therapies, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, USA. Electronic address: taylor.cohen@astrazeneca.com. |
